Skip to main content

Home/ Cancer/ Group items tagged probiotics

Rss Feed Group items tagged

Matti Narkia

Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disea... - 0 views

  •  
    Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.
    Kidd P.
    Altern Med Rev. 2003 Aug;8(3):223-46. Review.
    PMID: 12946237

    Th1 pathways typically produce activation
    of cytotoxic T lymphocytes (Tc), NK cells,
    macrophages, and monocytes, all of which can
    attack cancer cells and generally defend against
    tumors.55 IFN-gamma and other Th1 cytokines are
    typically lower in advanced cancer patients, while
    the Th2 marker IL-4 can be higher or unchanged
Matti Narkia

The application of probiotics in cancer - Br J Nutr. 2007 Oct (full text) - 0 views

  •  
    The application of probiotics in cancer.
    de Moreno de LeBlanc A, Matar C, Perdigón G.
    Br J Nutr. 2007 Oct;98 Suppl 1:S105-10. Review.
    PMID: 17922945
    doi:10.1017/S0007114507839602
Matti Narkia

Toward a Core Nutraceutical Program for Cancer Management -- McCarty and Block 5 (2): 1... - 0 views

  •  
    M. F. McCarty and K. I. Block
    Toward a core nutraceutical program for cancer management.
    Integr Cancer Ther, June 1, 2006; 5(2): 150 - 171.
1 - 3 of 3
Showing 20 items per page